新生儿持续肺动脉高压最新治疗进展(4)
[17]黄海波,刘海英,易璐,等.前列地尔联合常频通气治疗新生儿持续肺动脉高压疗效观察[J].中国实用儿科杂志,2012,27(12):940-941.
[18] Mei M,Cheng G,Sun B,et al.EDN1 Gene Variant is Associated with Neonatal Persistent Pulmonary Hypertension[J].Scientific Reports,2016,6(1):29877.
[19] More K,Athalye-Jape G K,Rao S C,et al.Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants:Reviews[M].Cochrane Database of Systematic Reviews.Cochrane Database Syst Rev,2016.
[20] Steinhorn R H,Fineman J,Kusic-Pajic A,et al.Bosentan as Adjunctive Therapy for Persistent Pulmonary Hypertension of the Newborn:Results of the Randomized Multicenter Placebo-Controlled Exploratory Trial[J].The Journal of Pediatrics,2016(177):90-96.
[21] Maneenil G,Thatrimontrichai A,Janjindamai W,et al.Effect of bosentan therapy in persistent pulmonary hypertension of the newborn[J].Pediatrics & Neonatology,2017,59(1):58-64.
[22]洪小楊,周更须,李秋平,等.体外膜肺氧合技术在新生儿呼吸衰竭中的应用[J].中国小儿急救医学,2014,21(10):629-632.
[23] K?ssel H,Bauer K,Kewitz G,et al.Do we need new indications for ECMO in neonates pretreated with high-frequency ventilation and/or inhaled nitric oxide?[J].Intensive Care Med,2000,26(10):1489-1495.
[24] Nakwan N,Chaiwiriyawong P.An international survey on persistent pulmonary hypertension of the newborn:A need for an evidence-based management[J].Journal of Neonatal-Perinatal Medicine,2016,9(3):243-250.
[25] Jonas P,Hedegaard E R,Ulf S,et al.Current and Future Treatments for Persistent Pulmonary Hypertension in the Newborn[J].Basic & Clinical Pharmacology & Toxicology,2018,123(4)., 百拇医药(朱玲)
[18] Mei M,Cheng G,Sun B,et al.EDN1 Gene Variant is Associated with Neonatal Persistent Pulmonary Hypertension[J].Scientific Reports,2016,6(1):29877.
[19] More K,Athalye-Jape G K,Rao S C,et al.Endothelin receptor antagonists for persistent pulmonary hypertension in term and late preterm infants:Reviews[M].Cochrane Database of Systematic Reviews.Cochrane Database Syst Rev,2016.
[20] Steinhorn R H,Fineman J,Kusic-Pajic A,et al.Bosentan as Adjunctive Therapy for Persistent Pulmonary Hypertension of the Newborn:Results of the Randomized Multicenter Placebo-Controlled Exploratory Trial[J].The Journal of Pediatrics,2016(177):90-96.
[21] Maneenil G,Thatrimontrichai A,Janjindamai W,et al.Effect of bosentan therapy in persistent pulmonary hypertension of the newborn[J].Pediatrics & Neonatology,2017,59(1):58-64.
[22]洪小楊,周更须,李秋平,等.体外膜肺氧合技术在新生儿呼吸衰竭中的应用[J].中国小儿急救医学,2014,21(10):629-632.
[23] K?ssel H,Bauer K,Kewitz G,et al.Do we need new indications for ECMO in neonates pretreated with high-frequency ventilation and/or inhaled nitric oxide?[J].Intensive Care Med,2000,26(10):1489-1495.
[24] Nakwan N,Chaiwiriyawong P.An international survey on persistent pulmonary hypertension of the newborn:A need for an evidence-based management[J].Journal of Neonatal-Perinatal Medicine,2016,9(3):243-250.
[25] Jonas P,Hedegaard E R,Ulf S,et al.Current and Future Treatments for Persistent Pulmonary Hypertension in the Newborn[J].Basic & Clinical Pharmacology & Toxicology,2018,123(4)., 百拇医药(朱玲)